Hims & Hers Health stock price forecast: Facing $33.50 resistance as HIMS adds 12.49%

Traders Union
All News
Financial News
Hims & Hers Health surges 12.49% today

Highlights

HIMS/USD demonstrates a short- and medium-term bullish setup after a 12.49% surge, but remains under long-term resistance with sellers still influential.
Momentum indicators are mixed as buyers dominate with intraday overbought readings, yet trend strength is unconfirmed and a short-term pullback risk exists.
Expected trading range is $28.29–$32.05 in coming sessions, with a 75% probability of sideways-to-upward movement unless support at $28.37 fails.

Mixed momentum and overbought signals as key supports hold

On the technical side, HIMS is trading above the MA-20 ($28.36) and MA-50 ($27.77), while remaining below the long-term MA-200 ($33.50). The Ichimoku Kijun level at $28.37 offers immediate support. Momentum readings are mixed: MACD signals a buy, but the ADX is neutral, indicating that trend strength is not firmly established. The RSI stands at 67.76, while both Stoch RSI and CCI, in addition to BBP, are overbought, aligning with buyer dominance seen through the Awesome Oscillator; however, overbought readings on multiple oscillators flag potential for profit-taking or a short-term reversal.

Upward bias dominates as support and resistance define scenarios

Over the next several sessions, HIMS is expected to trade within the $28.29–$32.05 volatility band. There is a 75% probability of an upward move, supported by buyers prevailing in the intraday context, and a 25% chance of a downside scenario if support at the Kijun level breaks. The base case envisions movement within a horizontal corridor; a breakout above resistance could open the way for further gains, while loss of support may trigger downside pressure.

Viktoras Karapetjanc, analyst at Traders Union, sees HIMS sustained by robust buyer demand and strong short-term momentum. The price is well above key moving averages and supported by confidence in the absence of negative news flow. Overbought signals warrant some caution, but prevailing sentiment favors further upside as long as support levels hold. He expects range trading, with a breakout above $32.05 opening new opportunities. "With bulls in control and technicals aligned, I expect buyers to defend support and target higher levels in the near term."

Earlier, analysts noted that Hims & Hers Health shares were displaying short-term bullish momentum but faced an uncertain outlook amid conflicting technical signals and overbought readings. The latest advance reinforces buyer strength and increases the probability of a volatility expansion, making a confirmed breakout above the prevailing resistance zone a key catalyst to monitor for directional conviction.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.